Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · IEX Real-Time Price · USD
13.55 -0.38 (-2.73%)
Oct 15, 2021 4:00 PM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
| Year | 2020 | 2019 |
|---|---|---|
| Selling, General & Admin | 1.35 | 0.93 |
| Research & Development | 8 | 8.58 |
| Operating Expenses | 9.35 | 9.5 |
| Operating Income | -9.35 | -9.5 |
| Other Expense / Income | -2.02 | -1.6 |
| Pretax Income | -7.33 | -7.91 |
| Net Income | -7.33 | -7.91 |
| Preferred Dividends | 0 | -0.22 |
| Net Income Common | -7.33 | -7.69 |
| Shares Outstanding (Basic) | 0 | 0 |
| Shares Outstanding (Diluted) | 0 | 0 |
| Shares Change | -2.71% | - |
| EPS (Basic) | -17.48 | -17.84 |
| EPS (Diluted) | -17.48 | -17.84 |
| Free Cash Flow Per Share | -17.77 | -15.83 |
| EBITDA | -7.33 | -7.91 |
| EBIT | -7.33 | -7.91 |